Afinitor
everolimus
- Strength
- 7.5 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor; mTOR Inhibitor Immuno…
Novartis Pharmaceuticals Corporation
Everolimus
Listed by Biocon Pharma Inc.
- Strength
- .5 mg/1
- Form
- Tablet
- Route
- Oral
- Class
- Kinase Inhibitor; mTOR Inhibitor Immunosuppre…
What it contains
- Everolimus .5 mg/1
FDA record
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor; mTOR Inhibitor Immunosuppressant |
| Approval route | ANDA — approved generic |
| NDC code | 70377-070 |
| FDA application | ANDA216140 |
| RxNorm concept | 977427 |
| Package sizes listed | 2 |
| Marketed since | June 2025 |
Other products containing Everolimus
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Afinitor
everolimus
- Strength
- 2.5 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor; mTOR Inhibitor Immuno…
Novartis Pharmaceuticals Corporation
Afinitor
everolimus
- Strength
- 10 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor; mTOR Inhibitor Immuno…
Novartis Pharmaceuticals Corporation
Afinitor
everolimus
- Strength
- 5 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor; mTOR Inhibitor Immuno…
Novartis Pharmaceuticals Corporation
Afinitor Disperz
everolimus
- Strength
- 3 mg/1
- Form
- Tablet, For Suspension
- Class
- Kinase Inhibitor; mTOR Inhibitor Immuno…
Novartis Pharmaceuticals Corporation
Afinitor Disperz
everolimus
- Strength
- 2 mg/1
- Form
- Tablet, For Suspension
- Class
- Kinase Inhibitor; mTOR Inhibitor Immuno…
Novartis Pharmaceuticals Corporation
Afinitor Disperz
everolimus
- Strength
- 5 mg/1
- Form
- Tablet, For Suspension
- Class
- Kinase Inhibitor; mTOR Inhibitor Immuno…
Novartis Pharmaceuticals Corporation
everolimus
- Strength
- 1 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor; mTOR Inhibitor Immuno…
Aurobindo Pharma Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.